Overview

Safety and Efficacy Study of Brimonidine in Patients With Glaucoma or Ocular Hypertension

Status:
Completed
Trial end date:
2004-09-01
Target enrollment:
Participant gender:
Summary
This study evaluates the safety and efficacy of brimonidine 0.1% ophthalmic solution compared with brimonidine 0.2% ophthalmic solution in patients with glaucoma or ocular hypertension
Phase:
Phase 3
Details
Lead Sponsor:
Allergan
Treatments:
Brimonidine Tartrate
Ophthalmic Solutions
Pharmaceutical Solutions